Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma

Clinical trial NCT00053950 · TERMINATED

Trial details

NCT number: NCT00053950
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Disseminated Neuroblastoma Recurrent Neuroblastoma

Start date: 2002-12-01
Primary completion: 2007-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.